🇺🇸 FDA
Patent

US 11028444

Survival predictor for diffuse large B cell lymphoma

granted A61PA61P35/00

Quick answer

US patent 11028444 (Survival predictor for diffuse large B cell lymphoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00